CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Planned sale President and CEO sold 100 shares at $30.00 ($3,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Scientific Officer sold 9,215 shares at an average $30.04 ($276,776)
- 4 Planned sale President and CEO sold 9,536 shares at an average $30.13 ($287,316)
- 4 Open-market sale Chief Business Officer sold 10,000 shares at $30.03 ($300,300)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale CMO sold 25,000 shares at $27.63 ($690,658)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale Chief Scientific Officer sold 100,000 shares at $27.37 ($2,737,470)
- 144 Insider Sale of Securities
Page 7 of 22 · 423 filings